HomeImmigration

Immigration

Jamaica Paper - Latest News and In-depth Analysis
Immigration

AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application

HONG KONG,Feb. 12,2025--AIM Vaccine Co.,Ltd. (06660.HK),a leading PRC vaccine company,published an announcement on February 11,2025,announced that its independently developed mRNA shingles vaccine has

Feb 13, 2025
Immigration

Hiking, fishing and skiing revealed as favourite Australian sporting holidays

BRISBANE,Australia,Feb. 12,2025-- More than a third of Australians have gone on a sporting or adventure holiday in the past 12 months and age doesn\'t seem to limit desire with close to 20 per cent ag

Feb 13, 2025
Immigration

/C O R R E C T I O N -- Appier/

In the news release,Appier Acquires AdCreative.ai in Strategic Move to Lead Generative AI-Powered Advertising and Marketing Innovation,issued 12-Feb-2025 by Appier over PR Newswire,we are advised by

Feb 13, 2025
Immigration

JX Luxventure Group Unveils 'LuxGent': A DeepSeek type Proprietary AI Chat Agent

HAIKOU,China,Feb. 12,2025-- JXLuxventure Group Inc. (Nasdaq: JXG) (the "Company"),a company in the wholesale trade sector specializing in duty-free and cross-border consumer goods,as well as

Feb 13, 2025
Immigration

MicroCloud Hologram Inc. Researches High-order Quantum Switch Technology to achieve quantum holographic communication

SHENZHEN,China,Feb. 12,2025-- MicroCloud Hologram Inc. (NASDAQ: HOLO),("HOLO" or the "Company"),a technology service provider,they are dedicated to advancing innovation and progres

Feb 13, 2025
Immigration

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC

HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult

Feb 13, 2025
1 ... 64 65 66 67 68 69 70 ... 100